Condition

T1DM clinical trials and research

• 6Clinical trials
• 5Countries

Newest T1DM clinical trials

All recruiting trials (6)

• Near-sensor insulin delivery with CGM in people with type 1 diabetes

  A small early-feasibility study tests a dual-port insulin patch pump that includes a CGM sensor to see if delivering insulin near the sensor affects glucose readings and whether an automated control algorithm can manage glucose.

  Recruiting Early Phase 1 ClinSurge Research · Toronto, Ontario · NCT07655076

• Pediatric Insulin Dose Calculator to Help Manage Type 1 Diabetes in Under-12s

  A digital tool that helps caregivers of children under 12 with Type 1 diabetes calculate insulin doses during meals, tested alongside standard care for 6 months.

  Recruiting at 2 sites Sultan Qaboos University · Mosul and 1 other locations · NCT07427134

• Tirzepatide added to an automated insulin delivery system to help adults with type 1 diabetes manage blood sugar

  This study tests whether once-weekly tirzepatide can help adults with type 1 diabetes use their insulin pumps more easily, possibly reducing the need to count carbohydrates at meals.

  Recruiting Phase 2/3 McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec and 3 other locations · NCT07284511

• CNP-103 treatment for adolescents and young adults recently diagnosed with stage 3 type 1 diabetes

  This trial will test whether multiple doses of CNP-103, compared with placebo, help people ages 12–35 who were diagnosed with stage 3 type 1 diabetes within the past 6 months.

  Recruiting at 45 sites Phase 1/2 COUR Pharmaceutical Development Company, Inc. · Tucson, Arizona and 44 other locations · NCT06783309

• Investigating the safety and effectiveness of porcine pancreatic cells in patients with Type 1 diabetes

  This study is testing if using pig pancreas cells can help adults with tough-to-manage Type 1 diabetes feel better and avoid dangerous low blood sugar episodes.

  Recruiting Phase 1/2 Otsuka Pharmaceutical Factory, Inc. · Chicago, Illinois · NCT06575426

• Long-term effects of immunomodulatory treatments in Type 1 Diabetes

  This study looks at people with Type 1 Diabetes who have tried certain treatments to see how long they can still make insulin and how their immune system changes over time.

  Recruiting at 8 sites National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 11 other locations · NCT02734277

Related topics

Quick answers

How many T1DM clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in United States (3 trials), Canada (2 trials), Iraq (1 trial), Pakistan (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Early Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →